| Line Item | 2025-08-31 | Y/Y |
|---|---|---|
| Revenue | $706K | +52.0% |
| Cost of Revenue | $3K | -43.6% |
| Gross Profit | $703K | +53.1% |
| R&D Expense | $8.2M | +249.0% |
| SG&A Expense | $4.3M | +12.8% |
| Operating Income | -$11.9M | -106.5% |
| Pre-tax Income | -$11.9M | -105.1% |
| Net Income | -$11.9M | -105.4% |
| EPS (Diluted) | -$0.66 |
| Line Item | 2025-08-31 | Y/Y |
|---|---|---|
| Short-term Investments | $22K | -60.4% |
| Accounts Receivable | $368K | +138.5% |
| Current Assets | $3.5M | -56.1% |
| Total Assets | $4.2M | -52.9% |
| Current Liabilities | $1.5M | +35.8% |
| Total Liabilities | $1.6M | +30.1% |
| Stockholders' Equity | $3.0M | -62.8% |
| Line Item | 2025-08-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.5M | -110.7% |
| Capital Expenditures | $25K | -42.7% |
| Investing Cash Flow | -$243K | -28.9% |
| Financing Cash Flow | $6.0M | -41.4% |
| Free Cash Flow | -$10.5M | -109.4% |
| -40.4% |